Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
endoscopy
MedTech
Jupiter exceeds $40M series B target for its TFX platform
Jupiter Endovascular raised more than its target of $40 million in fundraising it plans to use to develop and launch its TFX catheter platform.
Joseph Keenan
Oct 8, 2025 6:20am
CapsoVision seeks $30M IPO
May 12, 2025 11:00am
FDA clears first automated endoscope cleaning system
Mar 25, 2025 11:51am
Medtronic's latest PillCam completes first patient procedure
Dec 13, 2024 12:30pm
FDA clears Galvanize's pulsed field ablation needle in cancer
May 28, 2024 2:05pm
FDA OKs device that adds ultrasound to any upper GI endoscope
Jan 2, 2024 12:58pm